Literature DB >> 21918006

The accumulation of influenza A virus segment 7 spliced mRNAs is regulated by the NS1 protein.

Nicole C Robb1, Ervin Fodor1.   

Abstract

The influenza A virus M1 mRNA is alternatively spliced to produce M2 mRNA, mRNA(3), and in some cases, M4 mRNA. Splicing of influenza mRNAs is carried out by the cellular splicing machinery and is thought to be regulated, as both spliced and unspliced mRNAs encode proteins. In this study, we used radioactively labelled primers to investigate the accumulation of spliced and unspliced M segment mRNAs in viral infection and ribonucleoprotein (RNP) reconstitution assays in which only the minimal components required for transcription and replication to occur were expressed. We found that co-expression of the viral NS1 protein in an RNP reconstitution assay altered the accumulation of spliced mRNAs compared with when it was absent, and that this activity was dependent on the RNA-binding ability of NS1. These findings suggest that the NS1 protein plays a role in the regulation of splicing of influenza virus M1 mRNA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21918006     DOI: 10.1099/vir.0.035485-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  28 in total

1.  Identification of RNA partners of viral proteins in infected cells.

Authors:  Anastassia V Komarova; Chantal Combredet; Odile Sismeiro; Marie-Agnès Dillies; Bernd Jagla; Raul Yusef Sanchez David; Nicolas Vabret; Jean-Yves Coppée; Pierre-Olivier Vidalain; Frédéric Tangy
Journal:  RNA Biol       Date:  2013-04-01       Impact factor: 4.652

Review 2.  Species-Specific Host-Virus Interactions: Implications for Viral Host Range and Virulence.

Authors:  Stefan Rothenburg; Greg Brennan
Journal:  Trends Microbiol       Date:  2019-10-06       Impact factor: 17.079

3.  Influenza virus mRNA trafficking through host nuclear speckles.

Authors:  Amir Mor; Alexander White; Ke Zhang; Matthew Thompson; Matthew Esparza; Raquel Muñoz-Moreno; Kazunori Koide; Kristen W Lynch; Adolfo García-Sastre; Beatriz M A Fontoura
Journal:  Nat Microbiol       Date:  2016-05-27       Impact factor: 17.745

4.  Identification and characterization of viral defective RNA genomes in influenza B virus.

Authors:  Zizhang Sheng; Runxia Liu; Jieshi Yu; Zhiguang Ran; Simon J Newkirk; Wenfeng An; Feng Li; Dan Wang
Journal:  J Gen Virol       Date:  2018-02-12       Impact factor: 3.891

5.  Mutations in the M-gene segment can substantially increase replication efficiency of NS1 deletion influenza A virus in MDCK cells.

Authors:  R van Wielink; M M Harmsen; D E Martens; B P H Peeters; R H Wijffels; R J M Moormann
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

Review 6.  Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis.

Authors:  Aartjan J W Te Velthuis; Ervin Fodor
Journal:  Nat Rev Microbiol       Date:  2016-07-11       Impact factor: 60.633

7.  Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing.

Authors:  Pei-Ling Tsai; Ni-Ting Chiou; Sharon Kuss; Adolfo García-Sastre; Kristen W Lynch; Beatriz M A Fontoura
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

8.  Multifunctional adaptive NS1 mutations are selected upon human influenza virus evolution in the mouse.

Authors:  Nicole E Forbes; Jihui Ping; Samar K Dankar; Jian-Jun Jia; Mohammed Selman; Liya Keleta; Yan Zhou; Earl G Brown
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

9.  The influenza A segment 7 mRNA 3' splice site pseudoknot/hairpin family.

Authors:  Walter N Moss; Lumbini I Dela-Moss; Salvatore F Priore; Douglas H Turner
Journal:  RNA Biol       Date:  2012-10-12       Impact factor: 4.652

10.  Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain.

Authors:  Helen M Wise; Edward C Hutchinson; Brett W Jagger; Amanda D Stuart; Zi H Kang; Nicole Robb; Louis M Schwartzman; John C Kash; Ervin Fodor; Andrew E Firth; Julia R Gog; Jeffery K Taubenberger; Paul Digard
Journal:  PLoS Pathog       Date:  2012-11-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.